A clinical study evaluating a new hypothesis that an inexpensive drug with a simple treatment regimen can prevent Type 1 diabetes has been launched and is looking for participants. The autoimmune diabetes Accelerator Prevention Trial (adAPT) is led by Professor Terence Wilkin, of read more »